MITOCHONDRIAL HYPOXIA: PRODUCTION AND REACTION OF ROS
线粒体缺氧:ROS 的产生和反应
基本信息
- 批准号:6783211
- 负责人:
- 金额:$ 10.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-04-01 至 2009-07-31
- 项目状态:已结题
- 来源:
- 关键词:active sitesaginganimal tissuecardiolipinselectron transportelectrospray ionization mass spectrometryendoribonucleasesfree radical oxygenhigh performance liquid chromatographyhydrogen peroxideimmunochemistryisolation perfusionlaboratory ratlipid peroxidesmass spectrometrymethod developmentmitochondriamolecular sitemyocardial ischemia /hypoxiaoxidative stressprotein bindingprotein purificationprotein structure functionrecombinant proteinsreperfusion
项目摘要
Recent observations have led to the hypothesis that significant mitochondrial damage occurs during ischemia due to the production of reactive oxygen species (ROS) under the hypoxic and other conditions that prevail. Because of the difficulty of studying reactions at controlled PO2, few studies of mitochondrial ROS production during hypoxia exist. This absence of information leaves an unexplained conundrum: how does ROS production increase as the substrate 02, decreases. Defects identified in elderly heart mitochondria are hypothesized to augment ROS production during ischemia, resulting in increased oxidative damage during ischemic periods in the elderly heart.
The first two specific aims test two alternative mechanisms that could individually or in combination account for the enhanced production of ROS during ischemia. The first hypothesis is that the carriers in the electron transport chain are more reduced, resulting in sites of increased leakage to a low but nonzero 02 concentration, to generate . O2. The second
mechanism is that the enhanced ROS production comes from changes in the cellular environment induced as a response to ischemia and/or hypoxia. Among these cellular responses are the release of Fe, the influx of Ca ++, a decrease in pH, and the production of NO. A novel apparatus has been developed that permits the production of ROS to be monitored, concurrent with continuous respiratory utilization of 02 present at controlled variable partial pressures of 2-15 torr. Using submitochondrial particles, the variation in PO2 has been shown to alter both H202 and superoxide generation. The production of these and other ROS will be monitored as a function of the presence of Fe(II), Ca 2+, decreased pH and NO, all at concentrations mimicking physiological changes observed during ischemia. The response of both adult and elderly and
both subsarcolemmal and interfibrillar mitochondria will be compared. The site of ROS production, under conditions that lead to the greatest ROS generation, will be investigated by varying the reducing substrate in the presence of specific inhibitors as well as comparing results obtained with submitochondrial particles, mitoplasts and mitochondria.
In the third specific aim the chemical damage inflicted by the ROS on proteins and cardiolipin will be investigated by mass spectrometric methods. Methods of isolating the individual electron transport complexes for MS analyses have been developed so that the location of the most significant functional and structural damage can now be compared.
In the fourth specific aim, the variations in mitochondria detected or engineered by the other three projects will be mimicked in our system so that their effects on the direct production of mitochondrial ROS can be characterized.
Additionally, therapeutic interventions suggested by the PPG studies will be tested.
最近的观察已经导致了这样的假设,即在缺血期间由于在缺氧和其他条件下产生活性氧(ROS)而发生显著的线粒体损伤。由于在控制PO 2下研究反应的困难,很少有关于缺氧过程中线粒体ROS产生的研究。这种信息的缺乏留下了一个无法解释的难题:ROS的产生如何随着底物O2的减少而增加。在老年心脏线粒体中发现的缺陷被假设为在缺血期间增加ROS产生,导致老年心脏缺血期间氧化损伤增加。
前两个特定的目标测试两种替代机制,可以单独或组合的帐户在缺血过程中增加的ROS的生产。第一种假设是电子传输链中的载流子被更多地还原,导致泄漏增加到低但非零的O2浓度的位点,以产生。O2.第二
其机制是增强的ROS产生来自作为对缺血和/或缺氧的响应而诱导的细胞环境的变化。这些细胞反应包括Fe的释放、Ca ++的流入、pH的降低和NO的产生。已经开发了一种新的装置,其允许监测ROS的产生,同时在2-15 ℃的受控可变分压下连续呼吸利用存在的O2。使用亚线粒体颗粒,已经显示PO 2的变化改变H2 O2和超氧化物的产生。这些和其他ROS的产生将作为Fe(II)、Ca 2+、降低的pH和NO的存在的函数进行监测,所有这些都在模拟缺血期间观察到的生理变化的浓度下。成年人和老年人的反应,
将比较肌膜下和原纤维间线粒体。在导致最大ROS产生的条件下,ROS产生的位点将通过在特异性抑制剂存在下改变还原底物以及比较亚线粒体颗粒、有丝分裂体和线粒体获得的结果来研究。
在第三个具体目标中,将通过质谱方法研究ROS对蛋白质和心磷脂造成的化学损伤。已经开发了分离用于MS分析的单个电子传递复合物的方法,以便现在可以比较最显著的功能和结构损伤的位置。
在第四个具体目标中,将在我们的系统中模拟由其他三个项目检测或工程化的线粒体中的变化,以便可以表征它们对线粒体ROS直接产生的影响。
此外,还将对PPG研究建议的治疗干预进行测试。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vernon E. Anderson其他文献
Identification of a New Allelic Variant of the Acinetobacter baumannii Cephalosporinase , ADC-7-Lactamase : Defining a Unique Family of Class C Enzymes ‡
鲍曼不动杆菌头孢菌素酶 ADC-7-内酰胺酶新等位基因变体的鉴定:定义独特的 C 类酶家族 ‡
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:0
- 作者:
K. Hujer;N. Hamza;A. Hujer;Federico Perez;M. S. Helfand;C. Bethel;J. M. Thomson;Vernon E. Anderson;Miriam Barlow;Louis B. Rice;F. Tenover;R. Bonomo - 通讯作者:
R. Bonomo
Tazobactam Inactivation of SHV-1 and the Inhibitor-resistant Ser<sup>130</sup> → Gly SHV-1 β-Lactamase: INSIGHTS INTO THE MECHANISM OF INHIBITION
- DOI:
10.1074/jbc.m311669200 - 发表时间:
2004-05-07 - 期刊:
- 影响因子:
- 作者:
Doritza Pagan-Rodriguez;Xiang Zhou;Reiko Simmons;Christopher R. Bethel;Andrea M. Hujer;Marion S. Helfand;Zhaoyan Jin;Baochuan Guo;Vernon E. Anderson;Lily M. Ng;Robert A. Bonomo - 通讯作者:
Robert A. Bonomo
Vernon E. Anderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vernon E. Anderson', 18)}}的其他基金
Gel Permeation Chromatograph/Laser Light Scattering
凝胶渗透色谱/激光光散射
- 批准号:
6582604 - 财政年份:2003
- 资助金额:
$ 10.69万 - 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
- 批准号:
6359553 - 财政年份:2000
- 资助金额:
$ 10.69万 - 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
- 批准号:
6098817 - 财政年份:1999
- 资助金额:
$ 10.69万 - 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
- 批准号:
6218773 - 财政年份:1999
- 资助金额:
$ 10.69万 - 项目类别:
ISCHEMIC/REPERFUSION DAMAGE TO THE RIESKE IRON PROTEIN
RIESKE 铁蛋白的缺血/再灌注损伤
- 批准号:
6267775 - 财政年份:1998
- 资助金额:
$ 10.69万 - 项目类别:
相似国自然基金
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
- 批准号:82371603
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
- 批准号:82370743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
- 批准号:82371585
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
- 批准号:82370774
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
- 批准号:32000511
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
- 批准号:32000510
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
核膜蛋白调节人干细胞稳态和衰老的机制研究
- 批准号:31900523
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
FTO在调节人干细胞稳态和衰老中的作用
- 批准号:31900524
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
FGF-MAPK-PINK1介导线粒体自噬延缓人脂肪干细胞衰老
- 批准号:31900522
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
316LN锻造控氮奥氏体不锈钢热老化与应力腐蚀开裂敏感性研究
- 批准号:51071136
- 批准年份:2010
- 资助金额:35.0 万元
- 项目类别:面上项目
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
The Influence of Lifetime Occupational Experience on Cognitive Trajectories Among Mexican Older Adults
终生职业经历对墨西哥老年人认知轨迹的影响
- 批准号:
10748606 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Collaborative R&D
Bilingualism as a cognitive reserve factor: the behavioral and neural underpinnings of cognitive control in bilingual patients with aphasia
双语作为认知储备因素:双语失语症患者认知控制的行为和神经基础
- 批准号:
10824767 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Operating Grants
DNA repair pathway coordination during damage processing
损伤处理过程中 DNA 修复途径的协调
- 批准号:
10748479 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 10.69万 - 项目类别:
Studentship